AzTrials
AzTrials

Postprandial HyperglycemiaNCT03159065

Postprandial Efficacy of Probiotic Fruit Beverages on Glucose Tolerance and Insulin Resistance

A study testing Bilberry, Blackcurrant and Mango in people with Postprandial Hyperglycemia, run by Lund University.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Consumption of polyphenol-rich fruits and vegetables may improve the postprandial glucose and insulin responses and hence promote well-being. It has previously been observed that consumption of a bilberry drink decreases the postprandial insulin demand. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Postprandial Hyperglycemia
What is being tested?
Bilberry, Blackcurrant and Mango
Could I receive a placebo?
No, everyone receives an active treatment
How many people
12 participants
Where
No sites listed yet
Study dates
Sep 2014to Jan 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Healthy, not on medication, non-allergic, individuals aged 18-65 years old, having a BMI between 20-30 kg/m2 and also maintaining stable body weight, i.e. less than 5% weight change in the last three months before the study.

Who cannot join

  • -

About this study

Official title: Early Postprandial Efficacy of Probiotic Fruit Beverages on Glucose Tolerance and Insulin Resistance in Healthy Adults

Consumption of polyphenol-rich fruits and vegetables may improve the postprandial glucose and insulin responses and hence promote well-being. It has previously been observed that consumption of a bilberry drink decreases the postprandial insulin demand. In the present study, the impact of probiotic fruit beverages with different polyphenol profiles on the postprandial levels of glucose and insulin, were investigated.

Being tested
Bilberry, Blackcurrant, Mango, Beetroot, Rose hip
Medical subject headings
Hyperglycemia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • BilberryOther

    Fruit beverage with bilberry and fermented oatmeal

  • BlackcurrantOther

    Fruit beverage with blackcurrant and fermented oatmeal

  • MangoOther

    Fruit beverage with mango and fermented oatmeal

  • BeetrootOther

    Fruit beverage with beetroot and fermented oatmeal

  • Rose hipOther

    Fruit beverage with rose hip and fermented oatmeal

  • Glucose drinkOther

    A reference glucose drink

Study groups in NCT03159065
Study groupRoleWhat they receive
BilberryExperimentalA bilberry-based beverage with fermented oatmeal
Receives: Other: Bilberry
BlackcurrantExperimentalA blackcurrant-based beverage with fermented oatmeal
Receives: Other: Blackcurrant
MangoExperimentalA mango-based based beverage with fermented oatmeal
Receives: Other: Mango
BeetrootExperimentalA beetroot-based based beverage with fermented oatmeal
Receives: Other: Beetroot
Rose hipExperimentalA rose hip-based based beverage with fermented oatmeal
Receives: Other: Rose hip
Glucose drinkActive comparatorA reference glucose drink
Receives: Other: Glucose drink

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Efficacy of the study products on the postprandial serum insulin

    The postprandial incremental area under the curve for serum insulin

    Measured: Incremental area under the curve for serum insulin from 0 min up to 120 min following the ingestion of the study product

Secondary outcomes (1)
  1. Efficacy of the study products on the postprandial serum glucose

    The postprandial incremental area under the curve for serum glucose

    Measured: Incremental area under the curve for serum glucose from 0 min up to 120 min following the ingestion of the study product

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 May 2017
  2. Study startSep 2014
  3. Primary completionNov 2014
  4. Study completionJan 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Screening
Allocation
Randomised
Intervention model
Crossover
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
12 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03159065
Sponsor's protocol ID
InVeg (1)
Status last verified
May 2017
First submitted
17 May 2017
Last updated
19 May 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Xu J, Jonsson T, Plaza M, Hakansson A, Antonsson M, Ahren IL, Turner C, Spegel P, Granfeldt Y. Probiotic fruit beverages with different polyphenol profiles attenuated early insulin response. Nutr J. 2018 Feb 27;17(1):34. doi: 10.1186/s12937-018-0335-0.

    PubMed 29486772

Questions about this trial

What is this clinical trial studying?

A study testing Bilberry, Blackcurrant and Mango in people with Postprandial Hyperglycemia, run by Lund University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 May 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Efficacy of the study products on the postprandial serum insulin (time frame: Incremental area under the curve for serum insulin from 0 min up to 120 min following the ingestion of the study product). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03159065, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 May 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in